Psychiatry and Neurology, Neurology · Elkhart, IN
NPI
1265437404
Since 2005
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
303 S Nappanee St
Elkhart, IN, 46514
Phone (574) 296-3282
Groups this clinician bills Medicare through
Medicare paid, 2024
$185K
12,745 services
Medicare patients, 2024
476
Average age 74
Drug cost, 2024
$1.2M
4,849 prescriptions
Company payments, 2025
$3,483
From 32 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Thomas R Vidic was code J0585 (injection, onabotulinumtoxina, 1 unit), 9,100 times for 11 patients. In total Thomas R Vidic billed 12,745 services in 67 codes, and Medicare paid $185K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-12-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 9,100 | 11 | $4.99 | $45K |
| A9585 Injection, gadobutrol, 0.1 ml | Office | 1,000 | 12 | $0.22 | $221 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 809 | 368 | $11.30 | $9,143 |
| 99214 Office E&M - Established | Office | 610 | 316 | $84.25 | $51K |
| 99215 Office E&M - Established | Office | 178 | 128 | $112.50 | $20K |
| 36415 Venipuncture Blood Collection | Office | 117 | 99 | $8.65 | $1,012 |
| 96127 Behavioral Health Services | Office | 94 | 92 | $3.14 | $295 |
| 85651 Clinical Chemistry | Office | 71 | 67 | $4.18 | $297 |
| 99205 Office E&M - New | Office | 71 | 71 | $144.85 | $10K |
| 82746 Clinical Chemistry | Office | 63 | 62 | $14.41 | $908 |
| 82607 Clinical Chemistry | Office | 57 | 57 | $14.78 | $842 |
| 84443 Clinical Chemistry | Office | 49 | 49 | $16.46 | $807 |
| 84439 Clinical Chemistry | Office | 48 | 48 | $8.84 | $424 |
| 95886 Electrical Nerve Conductivity | Office | 35 | 32 | $67.13 | $2,349 |
| 93660 Cardiography | Facility | 31 | 31 | $67.79 | $2,102 |
By year: 2022 $234K for 14,695 services; 2023 $190K for 13,165 services; 2024 $185K for 12,745 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 117 | 99 | $8.65 | $1,012 |
| 85651 Clinical Chemistry | 71 | 67 | $4.18 | $297 |
| 82746 Clinical Chemistry | 63 | 62 | $14.41 | $908 |
| 82607 Clinical Chemistry | 57 | 57 | $14.78 | $842 |
| 84443 Clinical Chemistry | 49 | 49 | $16.46 | $807 |
| 84439 Clinical Chemistry | 48 | 48 | $8.84 | $424 |
| 83036 Blood Count | 18 | 18 | $9.52 | $171 |
Medicare prescription drug claims, 2024
In 2024, the drug Thomas R Vidic prescribed most often to Medicare patients was Donepezil Hcl, with 780 prescriptions and refills. In total Thomas R Vidic wrote 4,849 Medicare prescriptions that cost $1.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Donepezil Hcl Generic | 780 | 1,707 | 199 | $7,935 |
| Levetiracetam Generic | 415 | 871 | 94 | $17K |
| Lamotrigine Generic | 401 | 922 | 102 | $11K |
| Memantine Hcl Generic | 363 | 742 | 95 | $13K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 339 | 839 | 100 | $7,238 |
| Duloxetine Hcl Generic | 189 | 417 | 56 | $4,206 |
| Midodrine Hcl Generic | 143 | 303 | 51 | $12K |
| Zonisamide Generic | 140 | 295 | 40 | $5,578 |
| Baclofen Generic | 133 | 267 | 33 | $3,713 |
| Topiramate Generic | 130 | 337 | 47 | $1,764 |
| Fludrocortisone Acetate Generic | 121 | 238 | 30 | $3,939 |
| Fycompa Perampanel | 111 | 128 | 17 | $153K |
| Lacosamide Generic | 100 | 148 | 12 | $17K |
| Gabapentin Generic | 98 | 258 | 29 | $2,170 |
| Clopidogrel Clopidogrel Bisulfate | 96 | 249 | 30 | $754 |
Brand drugs: 376 claims; generic drugs: 4,473 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Thomas R Vidic $3,483 ($3,483 in general payments such as food, travel and fees) from 32 companies. The largest payer was Alexion Pharmaceuticals, Inc. with $287.
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. AZN | 5 | $287 |
| Vanda Pharmaceuticals Inc. VNDA | 6 | $283 |
| Lundbeck LLC | 9 | $258 |
| Catalyst Pharmaceuticals, Inc. CPRX | 10 | $244 |
| Biogen, Inc. BIIB | 4 | $232 |
| Argenx US, Inc. ARGX | 7 | $179 |
| UCB, Inc. UCB.BR | 13 | $170 |
| Celgene Corporation BMY | 7 | $167 |
| Eisai Inc. 4523.T | 5 | $132 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 6 | $123 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.